PDS Biotechnology Corporation - Common Stock (PDSB)
0.5853
+0.1862 (46.65%)
NASDAQ· Last Trade: Sep 15th, 7:18 PM EDT
Detailed Quote
| Previous Close | 0.3991 |
|---|---|
| Open | 0.4916 |
| Bid | 0.6019 |
| Ask | 0.6021 |
| Day's Range | 0.4130 - 0.7553 |
| 52 Week Range | 0.1952 - 1.550 |
| Volume | 371,456,905 |
| Market Cap | 16.66M |
| PE Ratio (TTM) | -0.7138 |
| EPS (TTM) | -0.8 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 47,601,712 |
Chart
About PDS Biotechnology Corporation - Common Stock (PDSB)
PDS Biotechnology Corp is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapy treatments for cancer and infectious diseases. The company’s proprietary technology platform aims to harness the body’s immune system to target and eliminate tumors, utilizing a novel approach that combines antigen discovery and immune system activation. With a commitment to advancing personalized medicine, PDS Biotechnology is engaged in creating therapies that seek to enhance patient outcomes and offer new hope for those battling difficult-to-treat diseases. Read More
News & Press Releases
Sept. 15, 2026 - Small-cap stocks PDS Biotechnology Corporation (NASDAQ: PDSB), IGC Pharma, Inc. (NYSE: IGC), Peraso Inc. (NASDAQ: PRSO) and ReTo Eco-Solutions, Inc. (NASDAQ: RETO) are in focus following recent pullbacks, with each company carrying potential catalysts across cancer immunotherapy, Alzheimer's biotechnology and AI, military autonomy, defense technology and intelligent industrial equipment .
Via AB Newswire · September 15, 2026
Sept. 15, 2026 - Investors looking across emerging-growth and small-cap stocks are watching Veea Inc. (NASDAQ: VEEA), Sphere 3D Corp. d/b/a DarkHorse Technologies (NASDAQ: ANY), DataMEDS AI, Inc. (NASDAQ: MEDS), MySize, Inc. (NASDAQ: MYSZ) and PDS Biotechnology Corporation (NASDAQ: PDSB) as developments spanning AI healthcare, AI infrastructure, GPU computing, defense technology and cancer immunotherapy create potential catalysts across the group.
Via AB Newswire · September 15, 2026
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.chartmill.com
Via Chartmill · September 15, 2026
Tuesday's session: most active stockschartmill.com
Via Chartmill · September 15, 2026
PDS Biotech (NASDAQ:PDSB) Posts Narrower Q1 Loss, Pre-Market Rises Over 5%chartmill.com
Via Chartmill · May 13, 2026
Unusual volume stocks are being observed in Tuesday's session.chartmill.com
Via Chartmill · September 15, 2026
Keep an eye on the top gainers and losers in Tuesday's session.chartmill.com
Via Chartmill · September 15, 2026
What's going on in today's after hours sessionchartmill.com
Via Chartmill · September 14, 2026
What's going on in today's sessionchartmill.com
Via Chartmill · September 14, 2026
The trading volume of these stocks is deviating from the norm in today's session.chartmill.com
Via Chartmill · September 9, 2026
Top movers analysis one hour before the close of the markets on 2026-09-08: top gainers and losers in today's session.chartmill.com
Via Chartmill · September 8, 2026
Sept. 8, 2026 Mobix Labs Inc. (NASDAQ: MOBX) and Peraso Inc. (NASDAQ: PRSO) are gaining attention across the expanding defense technology market, with Mobix Labs securing its initial production order supporting the F-16 Fighting Falcon and Peraso positioning its 60GHz mmWave technology across military robotics, UAVs and autonomous systems .
Via AB Newswire · September 8, 2026
Curious about the most active stocks on Tuesday?chartmill.com
Via Chartmill · September 8, 2026
Gainers Indaptus Therapeutics (NASDAQ:INDP) stock increased by 46.7% to $1.79 during Tuesday's regular session. The market value of their outstanding shares is at $162.5 million. PDS Biotechnology (NASDAQ:PDSB)
Via Benzinga · September 8, 2026
Top movers analysis in the middle of the day on 2026-09-08: top gainers and losers in today's session.chartmill.com
Via Chartmill · September 8, 2026
There are notable gap-ups and gap-downs in today's session.chartmill.com
Via Chartmill · September 8, 2026
These stocks have an unusual volume in today's sessionchartmill.com
Via Chartmill · August 13, 2026
What's going on in today's sessionchartmill.com
Via Chartmill · August 11, 2026
Here are the top movers in Tuesday's session.chartmill.com
Via Chartmill · August 11, 2026
Traders are paying attention to the gapping stocks in Tuesday's session.chartmill.com
Via Chartmill · August 11, 2026
PDSB Q4 2025 Earnings Call Transcript
Via The Motley Fool · May 27, 2026
PDSB Q1 2026 Earnings Transcript
Via The Motley Fool · May 13, 2026
PDS Biotechnology (NASDAQ:PDSB) reported a smaller first-quarter loss and highlighted changes to its late-stage head and neck cancer trial that management said could shorten development timelines and reduce costs.
On the company’s first quarter 2026 earnings call, Chief Executive Officer Dr. Frank
Via MarketBeat · May 13, 2026
What's going on in today's after hours sessionchartmill.com
Via Chartmill · March 20, 2026
PDS Biotech (PDSB) Q3 2025 earnings beat EPS estimates, sparking a major pre-market surge. The clinical-stage biotech also announced key progress for its lead cancer therapy.
Via Chartmill · November 13, 2025